These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6299092)

  • 21. Treatment of cancer with anticoagulants: rationale in the treatment of melanoma.
    Ornstein DL; Zacharski LR
    Int J Hematol; 2001 Feb; 73(2):157-61. PubMed ID: 11372726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet aggregation inhibitors and cancer metastasis.
    Gastpar H
    Ann Chir Gynaecol; 1982; 71(3):142-50. PubMed ID: 6287902
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of heparin for treating human malignancies.
    Ornstein DL; Zacharski LR
    Haemostasis; 1999 Dec; 29 Suppl S1():48-60. PubMed ID: 10629404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Coagulo-fibrinolytic system and platelets in cancer--clinical and experimental study on the influence of coagulo-fibrinolytic system and platelets on tumor growth and metastasis].
    Ojiro M
    Igaku Kenkyu; 1983 Mar; 53(2):63-99. PubMed ID: 6375232
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathways of coagulation/fibrinolysis activation in malignancy.
    Zacharski LR; Wojtukiewicz MZ; Costantini V; Ornstein DL; Memoli VA
    Semin Thromb Hemost; 1992 Jan; 18(1):104-16. PubMed ID: 1574711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of bis-carbamoyloxymethyl derivatives of pyrroles and pyrrolizines against human tumor xenografts in nude mice.
    Anderson WK
    Cancer Res; 1982 Jun; 42(6):2168-70. PubMed ID: 6280852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of platelets in tumour angiogenesis?
    Pinedo HM; Verheul HM; D'Amato RJ; Folkman J
    Lancet; 1998 Nov; 352(9142):1775-7. PubMed ID: 9848370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells.
    Fuster MM; Brown JR; Wang L; Esko JD
    Cancer Res; 2003 Jun; 63(11):2775-81. PubMed ID: 12782582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basis for selection of anticoagulant drugs for therapeutic trials in human malignancy.
    Zacharski LR
    Haemostasis; 1986; 16(3-4):300-20. PubMed ID: 3019848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of RA 233 in the preparation of platelets, with the blood cell separator.
    Beyer JH; Hilgard P
    Blut; 1977 Jul; 35(1):75-6. PubMed ID: 890147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.
    Zacharski LR; Hommann M; Kaufmann R
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):777-84. PubMed ID: 15350179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
    Naoe Y; Inami M; Matsumoto S; Takagaki S; Fujiwara T; Yamazaki S; Kawamura I; Nishigaki F; Tsujimoto S; Manda T; Shimomura K
    Jpn J Cancer Res; 1998 Dec; 89(12):1306-17. PubMed ID: 10081492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of blood platelets and prostaglandins in blood-borne metastases].
    Tanaka K; Fukumoto S
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1944-7. PubMed ID: 6614932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.
    Mamytbeková A; Rezábek K; Kacerovská H; Grimová J; Svobodová J
    Neoplasma; 1986; 33(4):417-21. PubMed ID: 3762804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
    Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M
    Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo.
    Nierodzik ML; Klepfish A; Karpatkin S
    Thromb Haemost; 1995 Jul; 74(1):282-90. PubMed ID: 8578473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interim analysis of a double-blind phase-III clinical trial of adjuvant levamisole versus control in resectable Dukes-C colon cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
    Arnaud JP; Buyse M; Adloff M; Nordlinger B; Pector JC; Duez N
    Recent Results Cancer Res; 1988; 110():101-3. PubMed ID: 3043583
    [No Abstract]   [Full Text] [Related]  

  • 38. Pretreatment fibrinogen levels are associated with response to chemotherapy in patients with small cell carcinoma of the lung: Department of Veterans Affairs Cooperative Study 188.
    Meehan KR; Zacharski LR; Moritz TE; Rickles FR
    Am J Hematol; 1995 Jun; 49(2):143-8. PubMed ID: 7771466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignancy and haemostasis.
    Donati MB; Poggi A
    Br J Haematol; 1980 Feb; 44(2):173-82. PubMed ID: 6990959
    [No Abstract]   [Full Text] [Related]  

  • 40. Heparin treatment of malignancy: the case for clinical trials in colon cancer.
    Zacharski LR
    Thromb Res; 2003 Jun; 110(4):213-4. PubMed ID: 14512084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.